FilingSEC EDGAR424B7
OS Therapies Announces Clinical Data and Launches $75 Million ATM Offering
· SEC accepted
StageClinical and Financing
Filing content
The company announced Phase IIb clinical survival data and initiated an at-the-market offering program for up to $75 million.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…